{"title":"PDT在肿瘤学实践中的机会","authors":"M. Gelfond","doi":"10.1117/12.640040","DOIUrl":null,"url":null,"abstract":"The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.","PeriodicalId":219206,"journal":{"name":"Current Research on Laser Use in Oncology","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2005-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"PDT opportunities in oncology practice\",\"authors\":\"M. Gelfond\",\"doi\":\"10.1117/12.640040\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.\",\"PeriodicalId\":219206,\"journal\":{\"name\":\"Current Research on Laser Use in Oncology\",\"volume\":\"17 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2005-08-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Research on Laser Use in Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1117/12.640040\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research on Laser Use in Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1117/12.640040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
